The numbers get crazy if it works in all these can
Post# of 148187
(Total Views: 340)
Posted On: 12/07/2019 2:34:02 PM
Re: craigakess #12158
The numbers get crazy if it works in all these cancer, I know.
Cancer drugs expected to top 200B in a sales in global market in a couple years.
https://www.genengnews.com/a-lists/top-10-bes...s-of-2018/
If leronlimab made a huge success and cracked top 15 in sales, say 2B, bottom of list, at 4x P/E, 8B marker cap, fully authorize, 700M A/S, that gives 45 per share. Sounds crazy sitting at 30c, I know. A lot of things with cancer would have to go right, so far patient one is giving the exact results we expect. Also, if results like that continue, if the market cap stays this low, some BP will probably swoop in and buy it all for $5 before we would ever get to see how far it goes. That would not happen you say? Well the same people selling millions right now at 30c, would vote yes on remaining shares. A lot of others have been waiting years for a pay off, and would take the easy path if offered say in February. So they probably have enough combined to agree to a buyout in that range. Unless of course the market cap appreciates according, much less would agree to a $5 buyout if the price was say $4 right now. This stock would have to go to $26 to match my highest other otc roi this year. I’m not expecting that this year, but when an otc stock makes the hot list, you would be amazed at the amount of money that can flow into the stock.
Cancer drugs expected to top 200B in a sales in global market in a couple years.
https://www.genengnews.com/a-lists/top-10-bes...s-of-2018/
If leronlimab made a huge success and cracked top 15 in sales, say 2B, bottom of list, at 4x P/E, 8B marker cap, fully authorize, 700M A/S, that gives 45 per share. Sounds crazy sitting at 30c, I know. A lot of things with cancer would have to go right, so far patient one is giving the exact results we expect. Also, if results like that continue, if the market cap stays this low, some BP will probably swoop in and buy it all for $5 before we would ever get to see how far it goes. That would not happen you say? Well the same people selling millions right now at 30c, would vote yes on remaining shares. A lot of others have been waiting years for a pay off, and would take the easy path if offered say in February. So they probably have enough combined to agree to a buyout in that range. Unless of course the market cap appreciates according, much less would agree to a $5 buyout if the price was say $4 right now. This stock would have to go to $26 to match my highest other otc roi this year. I’m not expecting that this year, but when an otc stock makes the hot list, you would be amazed at the amount of money that can flow into the stock.
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼